Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers

Annals of the New York Academy of Sciences

Volumn 1064, Issue , 2005, Pages 61-77

  Wang, Sumei ^a   Melhem, Elias R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Diffusion tensor imaging (DTI); Magnetic resonance spectroscopy (MRS); Magnetization transfer imaging (MTI); Primary lateral sclerosis (PLS); Upper motor neuron (UMN)

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN METABOLISM; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DISEASE COURSE; EARLY DIAGNOSIS; HUMAN; METABOLITE; MOTOR CORTEX; MOTOR NEURON DISEASE; NERVE CELL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIMARY LATERAL SCLEROSIS; PROTON NUCLEAR MAGNETIC RESONANCE; PYRAMIDAL TRACT;

EID: 29744444336     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1340.013     Document Type: Conference Paper

References (66)

1. BROWNELL, B., D.R. OPPENHEIMER & J.T. HUGHES. 1970. The central nervous system in motor neurone disease. J. Neurol. Neurosurg. Psychiatry 33: 338-357.
2. ROWLAND, L.P. 1998. Diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 160: S6-S24.
3. PRINGLE, C.E., A.J. HUDSON, D.O. MUÑOZ et al. 1992. Primary lateral sclerosis: clinical features, neuropathology, and diagnostic criteria. Brain 115: 495-520.
4. CHAN, S., P. KAUFMANN, D.C. SHUNGU & H. MITSUMOTO. 2003. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging CLIN. N. Am. 13: 307-326.
5. ROWLAND, L.P. & N.A. SHNEIDER. 2001. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344: 1688-1700.
6. KUIPERS-UPMEIJER, J., A.E. DE JAGER, J.M. HEW SNOEK & T.W. VAN WEERDEN. 2001. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J. Neurol. Neurosurg. Psychiatry 71: 615-620.
7. EISEN, A. & M. WEBER. 2001. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 24: 564-573.
8. FISCHER, L.R., D.G. CULVER, P. TENNANT et al. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185: 232-240.
9. TAKAHASHI, T., S. YAGISHITA, N. AMANO et al. 1997. Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex. Acta Neuropathol. (Berl.) 94: 294-299.
10. TSUCHIYA, K., S. SHINTANI, M. KIKUCHI et al. 1999. Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy: a clinicopathological study. J. Neurol. Sci. 162: 174-178.
11. BEAL, M.F. & E.P. RICHARDSON, JR. 1981. Primary lateral sclerosis: a case report. Arch. Neurol. 38: 630-633.
12. SMITH. C.D. 2002. Serial MRI findings in a case of primary lateral sclerosis. Neurology 58: 647-649.
13. MILLER, R.G., T.L. MUNSAT, M. SWASH & B.R. BROOKS. 1999. Consensus guidelines for the design and implementation of clinical trials in ALS: World Federation of Neurology Committee on Research. J. Neurol. Sci. 169: 2-12.
14. INCE, P.G., J. EVANS, M. KNOPP et al. 2003. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 60: 1252-1258.
15. IWANAGA, K., S. HAYASHI, M. OYAKE et al. 1997. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J. Neurol. Sci. 146: 139-143.
16. LAWYER, T., JR. & M.G. NETSKY. 1953. Amyotrophic lateral sclerosis. AMA Arch. Neurol. Psychiatry 69: 171-192.
17. HONG, Y.H., K.W. LEE, J.J. SUNG et al. 2004. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J. Neurol. Sci. 227: 73-78.
18. ELLIS, C.M., A. SIMMONS, D.K. JONES et al. 1999. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 53: 1051-1058.
19. GRAHAM, J.M., N. PAPADAKIS, J. EVANS et al. 2004. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 63: 2111-2119.
20. SACH, M., G. WINKLER, V. GLAUCHE et al. 2004. Diffusion tensor MR1 of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 127: 340-350.
21. TOOSY, A.T., D.J. WERRING, R.W. OURELL et al. 2003. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 74: 1250-1257.
22. ULUG, A.M., T. GRUNEWALD, M.T. LIN et al. 2004. Diffusion tensor imaging in the diagnosis of primary lateral sclerosis. J. Magn. Reson. Imaging 19: 34-39.
23. YIN, H., C.C. LIM, L. MA et al. 2004. Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J. Neurol. 251: 1249-1254.
24. DA ROCHA, A.J., A.C. MAIA, JR., R.G. NOGUEIRA & H.M. LEDERMAN. 1999. Magnetic resonance findings in amyotrophic lateral sclerosis using a spin echo magnetization transfer sequence: preliminary report. Arq. Neuropsiquiatr. 57: 912-915.
25. DA ROCHA, A.J., A.S. OLIVEIRA, R.B. FONSECA et al. 2004. Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence. AJNR Am. J. Neuroradiol. 25: 1509-1515.
26. KATO, Y., K. MATSUMURA, Y. KINOSADA et al. 1997. Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. AJNR Am. J. Neuroradiol. 18: 1541-1547.
27. TANABE, J.L., M. VERMATHEN, R. MILLER et al. 1998. Reduced MTR in the corticospinal tract and normal T2 in amyotrophic lateral sclerosis. Magn. Reson. Imaging 16: 1163-1169.
28. BLOCK, W., J. KARITZKY, F. TRABER et al. 1998. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch. Neurol. 55: 93 1-936.
29. BOWEN, B.C., P.M. PATTANY, W.G. BRADLEY et al. 2000. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 21: 647-658.
30. CHAN, S., D.C. SHUNGU, A. DOUGLAS-AKINWANDE et al. 1999. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 212: 763-769.
31. KAUFMANN, P., S.L. PULLMAN, D.C. SHUNGU et al. 2004. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 62: 1753-1757.
32. HECHT, M.J., F. FELLNER, C. FELLNER et al. 2001. MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1-, and proton-density-weighted images. J. Neurol. Sci. 186: 37-44.
33. HECHT, M.J., F. FELLNER, C. FELLNER et al. 2002. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images. J. Neurol. Sci. 199: 59-65.
34. WARAGAI, M. 1997. MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology 39: 847-851.
35. ZHANG, L., A.M. ULUG, R.D. ZIMMERMAN et al. 2003. The diagnostic utility of FLAIR imaging in clinically verified amyotrophic lateral sclerosis. J. Magn. Reson. Imaging 17: 521-527.
36. CHEUNG, G., M.J. GAWEL, P.W. COOPER et al. 1995. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 194: 263-270.
37. MIROWITZ, S., K. SARTOR, M. GADO & R. TORACK. 1989. Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings. Radiology 172: 535-539.
38. KARANTANAS, A.H. 1998. Amyotrophic lateral sclerosis: unilateral T2-shortening on MRI. Comput. Med. Imaging Graphics 22: 353-355.
39. OBA, H., T. ARAKI, K. OHTOMO et al. 1993. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 189: 843-846.
40. HALLOREN, B. & P. SOURANDER. 1958. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3: 41-51.
41. BEAULIEU, C. 2002. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed. 15: 435-455.
42. CHENEVERT, T.L., J.A. BRUNBERG & J.G. PIPE. 1990. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 177: 401-405.
43. BASSER, P.J. & C. PIERPAOLI. 1996. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B111: 209-219.
44. VIRTA, A., A. BARNETT & C. PIERPAOLI. 1999. Visualizing and characterizing white matter fiber structure and architecture in the human pyramidal tract using diffusion tensor MRI. Magn. Reson. Imaging 17: 1121-1133.
45. SHIMONY, J.S., R.C. MCKINSTRY, E. AKBUDAK et al. 1999. Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. Radiology 212: 770-784.
46. ALBAYRAM, S., E.R. MELHEM, S. MORI et al. 2002. Holoprosencephaly in children: diffusion tensor MR imaging of white matter tracts of the brainstem-initial experience. Radiology 223: 645-651.
47. HOON, A.H., JR., W.T. LAWRIE, JR., E.R. MELHEM et al. 2002. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology 59: 752-756.
48. MORI, S., W.E. KAUFMANN, C. DAVATZIKOS et al. 2002. Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn. Reson. Med. 47: 215-223.
49. PAJEVIC, S. & C. PIERPAOLI. 1999. Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brain. Magn. Reson. Med. 42: 526-540.
50. MORI, S., B.J. CRAIN, V.P. CHACKO & P.C. VAN ZIJL. 1999. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann. Neurol. 45: 265-269.
51. MORI, S. & P.C. VAN ZIJL. 2002. Fiber tracking: principles and strategies-a technical review. NMR Biomed. 15: 468-480.
52. STIELTJES, B., W.E. KAUFMANN, P.C. VAN ZIJL et al. 2001. Diffusion tensor imaging and axonal tracking in the human brainstem. Neuroimage 14: 723-735.
53. XUE, R., P.C. VAN ZIJL, B.J. GRAIN et al. 1999. In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging. Magn. Reson. Med. 42: 1123-1127.
54. MELHEM, E.R., S. MORI, G. MUKUNDAN et al. 2002. Diffusion tensor MR imaging of the brain and white matter tractography. AJR Am. J. Roentgenol. 178: 3-16.
55. CLARK, C.A., T.R. BARRICK, M.M. MURPHY & B.A. BELL. 2003. White matter fiber tracking in patients with space-occupying lesions of the brain: a new technique for neurosurgical planning? Neuroimage 20: 1601-1608.
56. WOLFF, S.D. & R.S. BALABAN. 1994. Magnetization transfer imaging: practical aspects and clinical applications. Radiology 192: 593-599.
57. BLOCK, W., F. TRABER, S. FLACKE et al. 2002. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 23: 317-323.
58. CASTILLO, M., L. KWOCK & S.K. MUKHERJI. 1996. Clinical applications of proton MR spectroscopy. AJNR Am. J. Neuroradiol. 17: 1-15.
59. 1H-MRS evidence of neuro-degeneration and excess glutamate + glutamine in ALS medulla. Neurology 53: 71-79.
60. RODNEY, W.D., R.G. MILLER, D. GELINAS et al. 1998. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 50: 1800-1805.
61. SCHUFF, N., W.D. ROONEY, R. MILLER et al. 2001. Reanalysis of multislice (I)H MRSI in amyotrophic lateral sclerosis. Magn. Reson. Med. 45: 513-516.
62. 1H-magnetic resonance speetroscopy in amyotrophic lateral sclerosis. J. Neurol. Sci. 169: 84-86.
63. POHL, C., W. BLOCK, J. KAKITZKY et al. 2001. Proton magnetic resonance speetroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch. Neurol. 58: 729-735.
64. KALRA, S., N.R. CASHMAN, A. GENGE & D.L. ARNOLD. 1998. Recovery of N-acetyl-aspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9: 1757-1761.
65. DECHENT, P. P.J. POUWELS, B. WILKEN et al. 1999. Increase of total creatine in human brain after oral supplementation of creatine-monoliydrate. Am. J. Physiol. 277: R698-R704.
66. VIELHABER, S., J. KAUFMANN, M. KANOWSKi et al. 2001. Effect of creatine supplementation on metabolite levels in ALS motor cortices. Exp. Neurol. 172: 377-382.